NCT01330758View on ClinicalTrials.gov

A Study to Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and Females

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions

Healthy

Interventions

DRUG

AZD8931

40 mg AZD8931 wet granulation tablet formulation

DRUG

AZD8931

40 mg AZD8931 roller compacted tablet formulation

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY